Skip to main content
Veterinary Medicines

CEVAZURIL 50 MG/ML, ORAL SUSPENSION FOR PIGLETS AND CALVES

Not authorised
  • Toltrazuril

Product identification

Medicine name:
CEVAZURIL 50 MG/ML, ORAL SUSPENSION FOR PIGLETS AND CALVES
Cevazuril 50 mg/ml, orale suspensie voor biggen en kalveren
Active substance:
  • Toltrazuril
Target species:
  • Cattle
  • Pig (piglet)
  • Cattle (calf)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Toltrazuril
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Milk
        no withdrawal period
    • Pig (piglet)
      • Meat and offal
        77
        day
    • Cattle (calf)
      • Meat and offal
        63
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BC01
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:
  • Cardboard box of 1 bottle of 100 ml
  • 250 ml bottle
  • 1 litre bottle
  • Cardboard box of 1 bottle of 250 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CEVA Sante Animale B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 101977
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0195/001

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/10/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."